Clinical trial
A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas
NCT00001430 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001430 |
|---|---|
| Title | A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas |
| Official title | A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hodgkin's Disease, Non Hodgkin's Lymphoma |
| Intervention type | Drug, Procedure |
| Interventions | PBSC, IL-2, EPOCH II |
| Enrollment | 49 |
| Start date | Feb 1, 1995 |
| Completion | Jan 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: